Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ReShape Lifesciences Inc
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
July 09, 2024
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
May 15, 2024
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
May 14, 2024
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
April 01, 2024
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
March 28, 2024
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
March 04, 2024
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
February 22, 2024
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
January 24, 2024
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
December 20, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
December 12, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
November 21, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan
November 08, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update
November 06, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
September 29, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI
September 22, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System
September 21, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System
September 19, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device
September 14, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update
August 07, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Update
August 03, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Software
June 29, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meeting
June 28, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0
June 26, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® to Participate in Investor and Industry Conferences in June
June 14, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Reports First Quarter Ended March 31, 2023 Financial Results and Provides Corporate Update
May 15, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide Corporate Update
May 11, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the Keystone Symposia on Type 2 Diabetes
April 27, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Reports Year Ended December 31, 2022 Financial Results and Provides Corporate Update
April 25, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
April 20, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to its Obalon® Balloon System
April 11, 2023
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Tickers
RSLS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit